Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of bempedoic acid in statin-inadequately controlled hyperlipidemia
CTR20261586Phase 3Active
- Sponsor
- CSPC Ouyi Pharmaceutical
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bempedoic acid in familial hyperlipidemia, familial hypercholesterolemia (FH), sponsored by CSPC Ouyi Pharmaceutical. Started Jul 2026; status: active.
02
Drugs
bempedoic acid
03
Conditions
familial hyperlipidemiafamilial hypercholesterolemia (FH)
Beyond the preview
Go deeper on CTR20261586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261586.